We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9910:TWSEFeng Tay Enterprise Co., Ltd. Analysis

Data as of 2026-05-14 - not real-time

NT$70.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Feng Tay Enterprises is trading at TWD 70.5, modestly above its DCF‑derived fair value of TWD 66.7, placing it in a *fairly valued* zone. The stock sits below its 20‑day (73.2) and 50‑day (79.1) SMAs and the 200‑day SMA (107.3), confirming a bearish price trend, yet the MACD histogram is positive and the MACD line has crossed above its signal, signaling a potential short‑term rebound. RSI sits at 38, suggesting the shares are approaching oversold territory, while the price is near the identified support level of TWD 67.7 and well below the resistance at TWD 79.3. Fundamentals show a 5.4% revenue decline, but margins remain respectable (gross 22%, operating 7.6%) and free cash flow is healthy, supporting a 6.94% dividend yield that currently equals earnings (payout 100%). However, the high payout ratio and modest earnings growth raise questions about dividend sustainability. With a beta of 0.16 and stable volume, volatility remains elevated at 33% over 30 days, highlighting the need for careful timing.
Overall, the blend of a marginal premium to intrinsic value, technical signs of a bottoming process, strong cash generation, and an attractive yet risky dividend profile suggests a *hold* stance in the near term, a *buy* outlook for the medium horizon if earnings stabilize, and a cautious *hold* for the long run as cyclical consumer demand and geographic exposure continue to shape performance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI near oversold level indicating potential bounce
  • Positive MACD histogram despite bearish SMA positioning
  • Proximity to support at TWD 67.7 with stable volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests modest upside
  • Strong free cash flow supporting dividend and reinvestment
  • Potential earnings recovery improving dividend sustainability

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Cyclical consumer sector exposure
  • Geographic diversification across US, China, and Europe
  • High dividend payout ratio may limit future growth

Key Metrics & Analysis

Financial Health

Revenue Growth-5.40%
Profit Margin6.03%
P/E Ratio13.8
ROE19.15%
ROA8.68%
Debt/Equity23.09
P/B Ratio2.7
Op. Cash FlowNT$8.7B
Free Cash FlowNT$5.1B

Technical Analysis

TrendBearish
RSI38.0
SupportNT$67.70
ResistanceNT$79.30
MA 20NT$73.20
MA 50NT$79.07
MA 200NT$107.28
MACDBullish
VolumeStable
Fear & Greed Index89.52

Valuation

Fair ValueNT$66.70
Target PriceNT$99.80
Upside/Downside41.56%
GradeFair
TypeBlend
Dividend Yield6.94%

Risk Assessment

Beta0.16
Volatility33.32%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.